INVST’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

INVST’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$285K	Sell	1,802 -199	-10%	-$26.9K	0.03%	303
2026 Q1	$256K	Sell	2,001 -631	-24%	-$78.8K	0.03%	300
2025 Q4	$321K	Sell	2,632 -160	-6%	-$18.3K	0.03%	265
2025 Q3	$280K	Hold	2,792	–	–	0.03%	271
2025 Q2	$232K	Sell	2,792 -400	-13%	-$31.9K	0.03%	278
2025 Q1	$259K	Sell	3,192 -340	-10%	-$30.4K	0.04%	255
2024 Q4	$318K	Buy	3,532 +725	+26%	+$70.2K	0.04%	202
2024 Q3	$277K	Buy	2,807 +160	+6%	+$15.7K	0.03%	209
2024 Q2	$246K	Buy	+2,647	New	+$237K	0.03%	232

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

INVST's XBI Position: Q2 2026 in Review

INVST reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 9.9% in Q2 2026, selling an estimated $26.9K and leaving 1,802 shares worth $285K. The position accounts for 0.03% of the portfolio, ranked #303.

INVST first reported a position in XBI in Q2 2024 and has held it in 9 quarters since. The position peaked at $321K in Q4 2025. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

INVST held 1,802 shares of State Street SPDR S&P Biotech ETF worth $285K as of Q2 2026.
INVST sold 199 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $26.9K.
State Street SPDR S&P Biotech ETF made up 0.03% of INVST's portfolio in Q2 2026, its #303 holding.
INVST first reported a position in State Street SPDR S&P Biotech ETF in Q2 2024 and has held it in 9 quarters since.
INVST's State Street SPDR S&P Biotech ETF position peaked at $321K in Q4 2025.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on INVST's 13F filing for Q2 2026, filed 14 Aug 2026.